Personalized Treatment With Emerging BTK Inhibitor Options in CLL/SLL and MCL

Chair and Presenter, Anthony R. Mato, MD, MSCE, and Nirav Shah, MD, MS, discuss B-cell cancers in this CME activity titled “The Next Building Block for B-cell Cancer Care: Exploring Personalized Treatment With Emerging BTK Inhibitor Options in CLL/SLL and MCL.” For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/QXD865. CME credit will be available until September 8, 2022.

свернуть